CRIPTO3 and Alzheimer disease: On both microglia and astrocytes, the AD risk variant CR1*2 is associated with reduced protein expression yet paradoxically enhanced phagocytosis of complement‐opsonized cargos compared to CR1*1, an effect dependent on iC3b production and collaboration with CR3.